WallStreetZenWallStreetZen

NASDAQ: CRVO
Cervomed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CRVO

Based on 4 analysts offering 12 month price targets for Cervomed Inc

Min Forecast
$11.00+159.43%
Avg Forecast
$22.00+418.87%
Max Forecast
$31.00+631.13%

Should I buy or sell CRVO stock?

Based on 4 analysts offering ratings for Cervomed Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRVO stock forecasts and price targets.

CRVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-22
lockedlocked$00.00+00.00%2026-03-18
lockedlocked$00.00+00.00%2026-03-18Find Out Why

1 of 1

Forecast return on equity

Is CRVO forecast to generate an efficient return?

Company
-126.77%
Industry
94.37%
Market
175.99%
CRVO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CRVO forecast to generate an efficient return on assets?

Company
-89.05%
Industry
27.62%
CRVO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CRVO earnings per share forecast

What is CRVO's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$2.75
Avg 2 year Forecast
-$2.51
Avg 3 year Forecast
-$2.37

CRVO revenue forecast

What is CRVO's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%
CRVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRVO revenue growth forecast

How is CRVO forecast to perform vs Biotechnology companies and vs the US market?

Company
-100%
Industry
34.07%
Market
14.06%
CRVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRVO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRVO$4.24$22.00+418.87%Strong Buy
GNTA$1.68N/AN/A
GOSS$0.17$2.06+1,123.81%Hold
TVGN$9.46$100.00+957.08%Strong Buy
GRCE$2.38$8.00+236.13%Strong Buy
View Top Biotech Stocks

Cervomed Stock Forecast FAQ

Is Cervomed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CRVO) stock is to Strong Buy CRVO stock.

Out of 4 analysts, 3 (75%) are recommending CRVO as a Strong Buy, 1 (25%) are recommending CRVO as a Buy, 0 (0%) are recommending CRVO as a Hold, 0 (0%) are recommending CRVO as a Sell, and 0 (0%) are recommending CRVO as a Strong Sell.

If you're new to stock investing, here's how to buy Cervomed stock.

What is CRVO's earnings growth forecast for 2026-2028?

(NASDAQ: CRVO) Cervomed's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.05%.

Cervomed's earnings in 2026 is -$30,036,491.On average, 9 Wall Street analysts forecast CRVO's earnings for 2026 to be -$25,471,662, with the lowest CRVO earnings forecast at -$39,379,184, and the highest CRVO earnings forecast at -$17,012,896. On average, 8 Wall Street analysts forecast CRVO's earnings for 2027 to be -$23,200,498, with the lowest CRVO earnings forecast at -$41,738,305, and the highest CRVO earnings forecast at -$13,221,451.

In 2028, CRVO is forecast to generate -$21,972,792 in earnings, with the lowest earnings forecast at -$30,940,787 and the highest earnings forecast at -$11,763,202.

What is CRVO's revenue growth forecast for 2026-2028?

(NASDAQ: CRVO) Cervomed's forecast annual revenue growth rate of -100% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Cervomed's revenue in 2026 is $2,089,019.On average, 9 Wall Street analysts forecast CRVO's revenue for 2026 to be $0, with the lowest CRVO revenue forecast at $0, and the highest CRVO revenue forecast at $0. On average, 9 Wall Street analysts forecast CRVO's revenue for 2027 to be $0, with the lowest CRVO revenue forecast at $0, and the highest CRVO revenue forecast at $0.

In 2028, CRVO is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is CRVO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CRVO) forecast ROA is -89.05%, which is lower than the forecast US Biotechnology industry average of 27.62%.

What is CRVO's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CRVO price target, the average CRVO price target is $22.00, with the highest CRVO stock price forecast at $31.00 and the lowest CRVO stock price forecast at $11.00.

On average, Wall Street analysts predict that Cervomed's share price could reach $22.00 by Apr 23, 2027. The average Cervomed stock price prediction forecasts a potential upside of 418.87% from the current CRVO share price of $4.24.

What is CRVO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CRVO) Cervomed's current Earnings Per Share (EPS) is -$3.28. On average, analysts forecast that CRVO's EPS will be -$2.75 for 2026, with the lowest EPS forecast at -$4.25, and the highest EPS forecast at -$1.84. On average, analysts forecast that CRVO's EPS will be -$2.51 for 2027, with the lowest EPS forecast at -$4.51, and the highest EPS forecast at -$1.43. In 2028, CRVO's EPS is forecast to hit -$2.37 (min: -$3.34, max: -$1.27).

What is CRVO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CRVO) forecast ROE is -126.77%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.